The Ras oncogene mediates a variety of biological effects which promote tumorigenic transformation. However, activated forms of Ras also have a surprising number anti-transformation aspects. They can induce senesence, cell cycle arrest and even death by apoptosis. The mechanisms behind these anti-neolastic effects remain poorly understood. We have identified a family of novel Ras effectors which appear to mediate some of the anti-neoplastic activities of Ras. especialy apoptosis. We have now determined that at least three members of this family exhibit all the classic hall marks of Ras effectors yet also demonstrate the properties of tumor suppressors. Namely, the mediate inhibition of cell growth and transformation and are frequently down-regulated by epigenetic mechanisms during tumor development. We now have preliminary data that two other members of this family have similar properties. Thus, we have identified and partially characterized a novel class of Ras activated tumor suppressor.

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC010359-05
Application #
6948141
Study Section
(CCBB)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Ahmed-Choudhury, Jalal; Agathanggelou, Angelo; Fenton, Sarah L et al. (2005) Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res 65:2690-7
Elam, Candice; Hesson, Luke; Vos, Michele D et al. (2005) RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential. Cancer Res 65:3117-25
Vos, Michele D; Martinez, Alfredo; Elam, Candice et al. (2004) A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 64:4244-50
Armesilla, Angel L; Williams, Judith C; Buch, Mamta H et al. (2004) Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). J Biol Chem 279:31318-28
Dallol, Ashraf; Agathanggelou, Angelo; Fenton, Sarah L et al. (2004) RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res 64:4112-6
Eckfeld, Kristin; Hesson, Luke; Vos, Michele D et al. (2004) RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res 64:8688-93
Vos, Michele D; Martinez, Alfredo; Ellis, Chad A et al. (2003) The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J Biol Chem 278:21938-43
Vos, M D; Ellis, C A; Bell, A et al. (2000) Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 275:35669-72